ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

SpotRx Joins Zipdrug’s Pharmacy Network

The partnership enables health plan members to be connected to SpotRx

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that SpotRx has been selected as a Partner Pharmacy of Zipdrug, now part of IngenioRx, Inc., a wholly owned subsidiary of Anthem, Inc.

Zipdrug’s solution focuses on connecting consumers with mainly chronic conditions to high-performing independent pharmacies that have a proven track record of providing impactful clinical care with higher patient adherence rates, by delivering needed medications directly to a patient’s home, ultimately improving patient outcomes. In the Tucson area, SpotRx will be serving as Zipdrug’s only preferred pharmacy. IngenioRx members in the Tucson area utilizing retail pharmacies considered to be low-performing by IngenioRx or out of network will have the option to be connected by Zipdrug to SpotRx and have SpotRx transfer their medications. SpotRx is also working with Zipdrug in southern California as one of several preferred pharmacies.

“We are honored to have been selected by Zipdrug, a data-driven company focused on simplifying the pharmacy experience and dynamically allocating Medicare Advantage patients nationwide to independent pharmacies driving better adherence,” said Ed Kilroy, Chief Executive Officer at MedAvail. “Zipdrug’s Pharmacy Network is currently available in a number of states, including California, Arizona, and Florida. In the Tucson area in which we currently operate, thousands of lives are covered by IngenioRx. We are looking forward to expanding our partnership with Zipdrug in the coming months.”

“Our partnership with Zipdrug represents a significant milestone, underscoring our ability to meet important quality and performance thresholds to be selected as a Partner Pharmacy,” said Neil Prezioso, Chief Pharmacy Officer. “We are excited about the opportunity to provide a convenient, quality experience through SpotRx to patients served by Zipdrug.”

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.38
+0.00 (0.00%)
AAPL  284.15
+0.00 (0.00%)
AMD  217.60
+0.00 (0.00%)
BAC  54.09
+0.00 (0.00%)
GOOG  320.62
+0.00 (0.00%)
META  639.60
+0.00 (0.00%)
MSFT  477.36
-0.37 (-0.08%)
NVDA  179.59
+0.00 (0.00%)
ORCL  207.73
+0.00 (0.00%)
TSLA  446.74
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.